132 related articles for article (PubMed ID: 10956204)
1. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity.
Nudelman A; Rephaeli A
J Med Chem; 2000 Jul; 43(15):2962-6. PubMed ID: 10956204
[TBL] [Abstract][Full Text] [Related]
2. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer activity of glutamate prodrugs of all-trans retinoic acid.
Cui C; Zhang Y; Wang L; Liu H; Cui G
J Pharm Pharmacol; 2009 Oct; 61(10):1353-8. PubMed ID: 19814868
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro.
Gediya LK; Khandelwal A; Patel J; Belosay A; Sabnis G; Mehta J; Purushottamachar P; Njar VC
J Med Chem; 2008 Jul; 51(13):3895-904. PubMed ID: 18543902
[TBL] [Abstract][Full Text] [Related]
5. Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform.
Liang Z; Li J; Zhu B
Drug Des Devel Ther; 2020; 14():4519-4531. PubMed ID: 33149550
[TBL] [Abstract][Full Text] [Related]
6. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
Chen Z; Wang W; Pan J; Chen L; Xue Y
Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
[TBL] [Abstract][Full Text] [Related]
7. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs.
Xia Z; Wiebe LI; Miller GG; Knaus EE
Arch Pharm (Weinheim); 1999 Aug; 332(8):286-94. PubMed ID: 10489539
[TBL] [Abstract][Full Text] [Related]
9. Novel anticancer prodrugs of butyric acid. 2.
Nudelman A; Ruse M; Aviram A; Rabizadeh E; Shaklai M; Zimrah Y; Rephaeli A
J Med Chem; 1992 Feb; 35(4):687-94. PubMed ID: 1542095
[TBL] [Abstract][Full Text] [Related]
10. Nanoprodrug of retinoic acid-modified paclitaxel.
Zhou Z; Yan J; Sun T; Wang X; Xie Z
Org Biomol Chem; 2017 Nov; 15(45):9611-9615. PubMed ID: 29106434
[TBL] [Abstract][Full Text] [Related]
11. Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation.
Berkovitch G; Doron D; Nudelman A; Malik Z; Rephaeli A
J Med Chem; 2008 Dec; 51(23):7356-69. PubMed ID: 19007111
[TBL] [Abstract][Full Text] [Related]
12. The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs.
Rephaeli A; Entin-Meer M; Angel D; Tarasenko N; Gruss-Fischer T; Bruachman I; Phillips DR; Cutts SM; Haas-Kogan D; Nudelman A
Invest New Drugs; 2006 Sep; 24(5):383-92. PubMed ID: 16502348
[TBL] [Abstract][Full Text] [Related]
13. Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance.
Cutts SM; Nudelman A; Pillay V; Spencer DM; Levovich I; Rephaeli A; Phillips DR
Oncol Res; 2005; 15(4):199-213. PubMed ID: 17822280
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
15. Liposomes assembled from dimeric retinoic acid phospholipid with improved pharmacokinetic properties.
Lu L; Du Y; Ismail M; Ling L; Yao C; Fu Z; Li X
Eur J Pharm Sci; 2018 Jan; 112():186-194. PubMed ID: 29162478
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of butyric acid as potential anti-neoplastic agents.
Rephaeli A; Rabizadeh E; Aviram A; Shaklai M; Ruse M; Nudelman A
Int J Cancer; 1991 Aug; 49(1):66-72. PubMed ID: 1874573
[TBL] [Abstract][Full Text] [Related]
17. Combating metastasis of breast cancer cells with a carboplatin analogue containing an all-trans retinoic acid ligand.
Dai Y; Huang H; Zhu Y; Cheng J; Shen AZ; Liu Y
Dalton Trans; 2020 Apr; 49(16):5039-5043. PubMed ID: 32242881
[TBL] [Abstract][Full Text] [Related]
18. The role of intracellularly released formaldehyde and butyric acid in the anticancer activity of acyloxyalkyl esters.
Nudelman A; Levovich I; Cutts SM; Phillips DR; Rephaeli A
J Med Chem; 2005 Feb; 48(4):1042-54. PubMed ID: 15715472
[TBL] [Abstract][Full Text] [Related]
19. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
[TBL] [Abstract][Full Text] [Related]
20. New 3'-O-aromatic acyl-5-fluoro-2'-deoxyuridine derivatives as potential anticancer agents.
Szymańska-Michalak A; Wawrzyniak D; Framski G; Kujda M; Zgoła P; Stawinski J; Barciszewski J; Boryski J; Kraszewski A
Eur J Med Chem; 2016 Jun; 115():41-52. PubMed ID: 26994842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
